|
5-flouracil - anti-cancer drug (Barraza et al., 2015; Kacar, 2019) |
|
Albendazole - anti-worm drug (Rodríguez-Hidalgo et al., 2011) |
|
Amphotercin B - antifungal drugs (Mobasheri et al., 2016) |
|
Anakinra - used in arthritis therapy (Liebner et al., 2014) |
|
Camptothecin - chemotherapy agent (Ansari et al., 2018; Alinejad et al., 2020) |
|
Carmustine - chemotherapy agent (Wolski et al., 2017a; Mortazavifar et al., 2019) |
|
Chlortetracycline - antibiotic (Dowlatabadi et al., 2019) |
|
Cisplatin - chemotherapy agent (Panczyk et al., 2013) |
|
Curcurbitacin drug families (Patel et al., 2010a) |
|
Cyclosporine - immunosuppressant (Tokarský et al., 2011) |
|
Dicolofenac - anti-inflammatory agents (Karjiban et al., 2012) |
|
Doxorubicin - chemotherapy agent (Guo et al., 2010, 2012b; Yang et al., 2012; Yang C. et al., 2019; Yang Y.-L. et al., 2019; Zhang et al., 2012, 2014, 2018; Nie et al., 2013; Shan et al., 2014; Lin et al., 2014, 2019; Izadyar et al., 2016; Rungrotmongkol and Poo-arporn, 2016; Wolski et al., 2017b, 2018, 2019; Hu et al., 2017; Mousavi et al., 2018; Kordzadeh et al., 2019; Alinejad et al., 2020; Exner and Ivanova, 2020; Maleki et al., 2020; Pakdel et al., 2020; Koochaki et al., 2020; Li J. et al., 2020
|
|
Erlotinib - anti-cancer drugs (Hlaváč et al., 2018) |
|
Exemestane - breast cancer drug (Ghadri et al., 2020) |
|
Flavonoid (Myung et al., 2016; Laudadido et al., 2017) |
|
Flutamide - prostate cancer drug (Kamel et al., 2017) |
|
Fluvestrant - breast cancer drug (Ghadri et al., 2020) |
|
Gemcitabine - chemotherapy agent (Razmimanesh et al., 2015; Sgarlata et al., 2016; Ansari et al., 2018; Farzad and Hashemzadeh, 2020) |
|
GF-17 - antimicrobial peptide (Asadzadeh et al., 2020) |
|
Ibuprofen - pain medication and anti-inflammatory (Thota et al., 2016; Kacar, 2020) |
|
Ifofamide - chemotherapy agent (Mazloom-Jalali and Shariatinia, 2019; Shariatinia and Mazloom-Jalali, 2019) |
|
Insulin - diabetes treatment (Yang et al., 2011) |
|
Interferon - immunomodulator (Xu et al., 2018) |
|
Interferon Alpha - anti-cancer and anti-viral agent (Gupta et al., 2018) |
|
Itraconazole - antifungal drugs (Dzieciuch-Rojek et al., 2017; Poojari et al., 2019, 2020) |
|
Letrozole - breast cancer drug (Ghadri et al., 2020), |
|
Metronidazole antibiotic (Kumar et al., 2019) |
|
Nicotine (Zaboli and Raissi, 2017; Li Z. et al., 2020) |
|
Nystatin - antifungal drugs (Mobasheri et al., 2016) |
|
Paclitaxel (taxol) - chemotherapy agent (Guo et al., 2009a, 2012b; Loverde et al., 2011; Wang et al., 2013; Ghadari and Kashefi, 2017; Hasanzade and Raissi, 2017; Hashemzadeh and Raissi, 2017; Monpara et al., 2018) |
|
Piaglitazone (Zaboli and Raissi, 2017) |
|
Picoplatin - colorectal cancer drug (Farmanzadeh and Ghaderi, 2018) |
|
Piroxicam (Wilkosz et al., 2017) |
|
Prilocane - local anesthetic (Grillo et al., 2018) |
|
Sorafenib - kidney cancer drug (Dehneshin et al., 2019) |
|
Streptozotocin - neuendocrine tumors drug (Dehneshin et al., 2019) |
|
Sunitinib - renal carcinoma medication (Dehneshin et al., 2019) |
|
Tacrine - Alzheimer’s medication (Esalmi et al., 2016) |
|
Vinblastine - chemotherapy agent (Li et al., 2016a) |
